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Abstract
Human papillomavirus (HPV) causes cutaneous and mucosal
infections in both adults and children. In order to evaluate HPV
prevalence and the spectrum of genotypes in the oral cavity of
paediatric subjects, a retrospective study was carried out on
oral-pharyngeal swabs collected from 177 newborns aged 0–
6 months. HPV-DNA was detected by a nested-PCR; the viral
typing was made through DNA sequencing. HPV infection was
identiﬁed in 25 subjects (14.1%) and the sequence analysis
showed eight distinct genotypes. These data conﬁrm HPV detec-
tion in newborn oral mucosa. Further investigations are needed
to clarify the methods of HPV acquisition.
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Human papillomaviruses (HPVs) are small double-stranded
DNA viruses, grouped into cutaneous and mucosal types
according to the infection site, with a further subdivision
into high-risk (HR) and low-risk (LR) genotypes, depending
on their association with malignancy [1]. HPV is a common
pathogen in adults, but it is also associated with a variety
of mucosal and skin infections in the paediatric population.
Several studies have conﬁrmed the detection of HPV in
children, though the rates reported are controversial. HPV
DNA has been found in oral swabs of newborns in per-
centages varying from 4% to 87% [2,3]. HPV infection in
infant oral mucosa seems to be acquired at birth [2], prob-
ably due to exposure to the mother’s cervical HPV infec-
tion. The oral infection persists for at least 6 months, with
a decreasing rate during the ﬁrst 3 years of life [1,3–5].
Other potential ways of transmission, such as auto- and
hetero-inoculation, sexual abuse [6,7] and indirect transmis-
sion via fomites [7], are only hypothetical for the paediatric
population.
This study aims to assess the prevalence of HPV infection
and viral genotypes affecting the oral cavity of paediatric sub-
jects.
A retrospective study was carried out on oral-pharyngeal
swabs collected during a previous epidemiological-molecular
surveillance of respiratory infections in children. Samples
were collected from hospitalized children and routinely
tested for diagnosis of respiratory illness from 2009 through
to 2010 [8]. Written informed consent was obtained from
parents or legal guardians for each child included in the study
so as to store their samples for further anonymous research
testing.
Human papillomavirus testing was retrospectively per-
formed in 2011 on a subgroup of 177 samples belonging to
the population of babies aged 0–6 months. Among these
newborns, 58.8% (104/177) were male and 41.2% (73/177)
female. The median age was 3 months (IQR, 1–4 months). In
order to evaluate the age distribution of HPV infection, the
children were divided into seven age groups: 0–1 month
(14.7%; 95% CI, 10–20.5%), 1–2 months (18.1%; 95% CI,
12.9–24.3%), 2–3 months (16.4%; 95% CI, 11.5–22.4%), 3–
4 months (23.7%; 95% CI, 17.9–30.4%), 4–5 months (11.3%;
95% CI, 7.2–16.6%), 5–6 months (7.9%; 95% CI, 4.6–12.6%)
and 6–7 months (7.9%; 95% CI, 4.6–12.6%).
DNA was extracted from oral-pharyngeal samples by
using a commercial kit (NucliSENS miniMAG, bioMe´rieux
bv, Lyon, France). The concentration and purity of the
extracted DNA was evaluated through a spectrophotometer
(NanoDrop ND-2000/2000C, Euroclone, Thermo scientiﬁc,
Wilmington, DE, USA). HPV-DNA was detected through a
speciﬁc nested-PCR assay amplifying a 150 bp segment of
ORF L1 using the two primer pair: MY09/MY11 and GP5+/
GP6+ [9,10]. Each run was accompanied by positive (HPV-16
positive cells, Caski) and negative (water) control samples.
The DNA integrity was assessed by ampliﬁcation of a 268 bp
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fragment in the ubiquitous beta-globulin gene using the pri-
mer pair GH20 and PCO4. The ampliﬁcation products were
visualized using electrophoresis analysis in a 2% agarose gel
containing ethidium bromide (0.5 mg/L) and compared with a
standard (DNA Molecular Weight, Marker 100, Sigma-
Aldrich, St. Louis, MO, USA). The PCR products of approxi-
mately 150 bp from the revised L1 consensus PCR assays
underwent genotyping through automated DNA sequencing
on the ABI PRISM 3100 genetic analyser (Applied Biosys-
tems, Carlsbad, CA, USA). Data were expressed as median
(interquartile range, IQR) and percentages (95% conﬁdence
intervals, 95% CI) where appropriate. Comparisons between
groups were performed using the chi-square test or Fisher’s
exact test. A p-value <0.05 was considered statistically signif-
icant (two-tailed test). All statistical analyses were performed
using OpenEPI software, version 2.3.1 [11].
The overall prevalence of HPV infection among newborns
was 14.1% (25/177; 95% CI:,9.6–19.9%). The median age of
HPV-positive children was 4 months (IQR, 3–4 months), 52%
(13/25; 95% CI, 32.8–70.8%) were female and 48% (12/25;
95% CI, 29.2–67.3%) were male. Table 1 shows HPV-positive
rates and the identiﬁed genotypes by age group.
Ampliﬁed DNA from 14 out of 25 (56%) positive samples
underwent DNA sequencing and eight distinct HPV geno-
types were detected, ﬁve of which belonged to the mucosal
HR-HPV types (HPV-16,-18,-31,-33 and -58) and two to the
mucosal LR-HPV types (HPV -81 and -84) (Table 1). HPV-
81 was the prevalent mucosal genotype, identiﬁed in 5/25
(20%; 95% CI, 7.7–38.9%; p 0.13) samples (Fig. 1). Two
oral-pharyngeal swabs (8%) showed the cutaneous genotype
HPV-27.
The prevalence of HPV infection (14.1%) found in this
study is included in the wide spectrum of rates reported
for oral mucosa of paediatric populations [1,3,12]. This
variability depends on the type of the population studied,
the type of the sample analysed and the methods used
for HPV detection [13]. As for age, we found a higher rate
of infection (40%) in subjects aged 4–5 months than in
other age groups (p 0.01). The increasing exposure of
infants of this age to external contacts, beyond those with
their own mother, could explain this ﬁnding, but the num-
ber of individuals tested is too low to make deﬁnitive con-
clusions.
The same percentage (24%) of genotypes at high (HR) and
low (LR) oncogenic risk was associated with the mucosal
oral-pharyngeal HPV infections detected. The prevalent
genotype was LR-HPV-81, found in 20% of children, particu-
larly those aged 3–4 months. The identiﬁcation of high-onco-
genic-risk HPV genotypes in newborns’ respiratory tracts has
been reported [14,15] and the genotypes identiﬁed match
those frequently infecting the genital tract of childbearing-age
women [16]. This may support a potential transmission of
HPV infection from mothers to children. However, as a limi-
tation of this study, the lack of information concerning the
HPV status of the mothers does not allow deﬁnitive conclu-
sions to be drawn.
Long-term longitudinal studies could also clarify the natu-
ral history of HPV infection in the oral cavity of paediatric
subjects. The presence of viral genotypes in this site may be
associated with transient infections, similar to those affecting
TABLE 1. Distribution of HPV-positive rates and genotypes by age group
Age
group
(months)
No. of
children
%; 95% CI
(out of 177)
No. of
HPV+
individuals
% HPV+ per
age group;
95% CI
HPV genotype (No. of
positive samples)
0–1 26 14.7; 10–20.5 2 7.7; 1.3–23.2 NT(2)
1–2 32 18.1; 12.9–24.3 3 9.4; 2.4–23.4 HPV-27(2),-81(1)
2–3 29 16.4; 11.5–22.4 1 3.4; 0.2–15.9 HPV-84 (1)
3–4 42 23.7; 17.9–30.4 6 14.3; 6–27.4 HPV-18(1),-31(1),-33(1),-81(3)
4–5 20 11.3; 7.2–16.6 8 40.0; 20.6–62.1 HPV-16(1), -81(1), NT(6)
5–6 14 7.9; 4.6–12.6 3 21.4; 5.8–48 HPV-33(1), NT(2)
6–7 14 7.9; 4.6–12.6 2 14.3; 2.5–39.7 HPV-58(1), NT(1)
NT, non-typed.
FIG. 1. HPV genotypes identiﬁed in newborn oral mucosa.
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the genital level, or persistent ones, with an increasing risk
of progression to symptomatic clinical forms.
The unusual presence of HPV-27 in the oral mucosa of
two newborns requires further investigation, being a cutane-
ous genotype normally associated with the development of
common skin warts [12,17]. A possible source of acquisition
could be a direct contact with the mother, given the close
mother-child relationship in the postnatal period, or an indi-
rect transmission via fomites.
These preliminary data conﬁrm the HPV circulation in
newborns. Further studies involving a larger selection of sub-
jects are needed to clarify several crucial points, such as the
methods of HPV acquisition and the prognosis of infection.
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